首页> Bioanalysis> European Bioanalysis Forum recommendation on method establishment and bioanalysis of biomarkers in support of drug development

European Bioanalysis Forum recommendation on method establishment and bioanalysis of biomarkers in support of drug development

导出原文传递

翻译打印收藏纠错

作者： Timmerman,P. ^[1] ; Herling,C. ^[2] ; Stoellner,D. ^[3] ; Jaitner,B. ^[4] ; Pihl,S. ^[5] ; Elsby,K. ^[6] ; Henderson,N. ^[7] ; Barroso,B. ^[8] ; Fischmann,S. ^[9] ; Companjen,A. ^[10] ; Versteilen,A. ^[11] ; Bates,S. ; Kingsley,C. ; Kunz,U.

作者单位： NovoNordisk, Denmark ^[1] Novartis, United States ^[2] Boehringer-Ingelheim, Germany ^[3] AstraZeneca, United Kingdom ^[4] GlaxoSmithKline, United Kingdom ^[5] Crucell, Netherlands ^[6] Astellas, Netherlands ^[7] Janssen Research and Development, Belgium ^[8] Quotient Bioresearch, United Kingdom ^[9] Lundbeck, Denmark ^[10] Abbott, United States ^[11]

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Bioanalysis

2012年4卷15期

1883-1894页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

European Bioanalysis Forum recommendation on method establishment and bioanalysis of biomarkers in support of drug development

Bioanalysis

相似文献

Bioanalysis

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

European Bioanalysis Forum recommendation on method establishment and bioanalysis of biomarkers in support of drug development

Bioanalysis

相似文献

Bioanalysis

相关期刊

检索历史清除